首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 藥物開發 > 藥品開發領域之趨勢與新技術
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

藥品開發領域之趨勢與新技術

Trends and Emerging Technologies in Drug Discovery

出版商 Frost & Sullivan
出版日期 2005年12月 商品編碼 36014
內容資訊 英文 61 pages
價格
本報告書已不再販售

本報告已在2011年07月19日停止出版。

目錄

Abstract

Research Overview

This Research Service analyzes the emerging trends and technologies in the United States drug discovery industry. It provides a 30,000 foot view of the trends and near term forecasts in these areas while exploring the role these technologies may play in the future.

Table Of Contents

1. OVERVIEW OF TRENDS AND EMERGING TECHNOLOGIES IN DRUG DISCOVERY

Introduction

  • 1. Overview
  • 2. Scope and Segmentation
  • 3. Definitions and Acronyms

2. CELL-BASED SCREENING MARKET

Market Overview

  • 1. Introduction
  • 2. Segment Overview
  • 3. Market Challenges

4. Strategic Recommendations

Forecasts and Trends

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Competitive Segmentation
  • 4. Competitive Analysis
  • 5. Revenue Forecast

3. PROTEOMICS MASS SPECTROMETRY SOFTWARE MARKET

Market Overview

  • 1. Introduction
  • 2. Segment Overview
  • 3. Market Challenges
  • 4. Strategic Recommendations

Forecasts and Trends

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Competitive Segmentation
  • 4. Competitive Analysis
  • 5. Revenue Forecast

4. DNA MICROARRAY CLINICAL APPLICATION MARKET

Market Overview

  • 1. Introduction
  • 2. Segment Overview
  • 3. Market Challenges
  • 4. Strategic Recommendations

Forecasts and Trends

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Competitive Segmentation
  • 4. Competitive Analysis
  • 5. Revenue Forecast

5. DECISION SUPPORT DATABASE

Decision Support Database

  • 1. Number of Biotechnology Companies
  • 2. Private Investment in Biotechnology
  • 3. Government R&D Biotechnology Investment
  • 4. Percent of Investment into Biotechnology by Government
Back to Top